期刊文献+

再发子痫前期相关因素及母子转归的单中心临床研究 被引量:18

Risk factors of recurrent preeclampsia and its relation to maternal and offspring outcome
下载PDF
导出
摘要 目的:探讨再发子痫前期发病相关危险因素,观察再发子痫前期发病特征及远期母子预后。方法:选择2009年1月至2013年12月在浙江大学医学院附属妇产科医院住院分娩的有子痫前期史孕妇153人,其中可获得完整病史资料及随访资料者共115人,将其按是否再发子痫前期分为再发组和非再发组,分析病史、再发子痫前期病情和母子随访资料。结果:115例有子痫前期病史的孕妇再次妊娠时再发子痫前期82例(71.3%),发病年龄、妊娠间隔时间、是否正规产检、孕期体质量增加、体质量指数( BMI)、高脂血症、胎儿生长受限、母系家族史与子痫前期再发密切相关(均P <0.05)。 Logistic回归分析结果提示:妊娠间隔时间( OR=1.349,P=0.004)、BMI ( OR =1.249, P =0.004)、胎儿生长受限( OR =9.642,P=0.009)是预测子痫前期复发的主要危险因素。与第一次妊娠时子痫前期比较,再发子痫前期孕妇发病孕周、妊娠终止孕周更早,血压更高,尿蛋白达++及以上例数增加,并发症发生例数增加(均P<0.05);再发子痫前期子代早产(特别是小于34周的早产)发生例数增加,新生儿出生体质量更低(均P<0.05)。随访结果,孕妇产后发生远期高血压病例数再发组(47.5%)多于非再发组(23.3%, P<0.05);初次妊娠获得子代发生体质量过大例数再发组(31.25%)多于非再发组(6.70%,P<0.05)。结论:发病年龄、妊娠间隔时间、是否正规产检、孕期体质量增加、BMI、高脂血症、胎儿生长受限和母系家族史与子痫前期再发有密切相关,妊娠间隔时间、BMI和胎儿生长受限是预测子痫前期复发的主要危险因素,再发子痫前期具有更严重的临床结局,母子近期和远期并发症高,需重视预防。 Objective:To investigate the risks of recurrent preeclampsia and observe the incidence and long-term prognosis of recurrent preeclampsia . Methods: One hundred and fifteen women with preeclampsia history admitted in Women ’s Hospital , Zhejiang University School of Medicine from January 2009 to December 2013 were enrolled in the study .The clinical data were retrospectively analyzed .Results:Among 115 women with preeclampsia , 82 cases ( 71 .3%) had recurrent preeclampsia .The onset age, the pregnant interval time , regular prenatal check-up, weight gain during pregnancy, body mass index (BMI), hyperlipidemia, fetal growth restriction(FGR), maternal family history were closely associated with recurrent preeclampsia ( P 〈0.05).Logistic regression analysis showed that the pregnant interval time , BMI, FGR were independent risk factors for preeclampsia recurrence . Compared with the preeclampsia in first pregnancy , the mather had earlier onset and termination of pregnancy , higher blood pressure , higher rate of urine protein≥2+and higher rate of complications in recurrent preeclampsia .The offspring had higher rate of preterm birth , especially the time of birth for 34 weeks or earlier and lower birth weight ( P〈0.05) . The incidence of chronic hypertension in recurrent preeclampsia group was higher than that in no recurrence group (47.5%vs 23.3%, P〈0.05);the overweight rate of first pregnant offspring in recurrence group was higher than that in no recurrence group (31.25%vs 6.70%, P〈0.05).Conclusion: The onset age, time interval, regular prenatal check-up, weight gain during pregnancy , BMI, hyperlipidemia , FGR, maternal family history are closely associated with recurrent preeclampsia , and the pregnant interval time , BMI, FGR are independent risk factors for preeclampsia recurrence . Recurrent preeclampsia has more serious clinical outcome and complications, and prevention need to be emphasized .
作者 张坚贞 贺晶
出处 《浙江大学学报(医学版)》 CAS CSCD 北大核心 2015年第3期258-263,共6页 Journal of Zhejiang University(Medical Sciences)
基金 卫生行业科研专项(201402006)
关键词 子痫 妊娠并发症 发病年龄 胎儿生长迟缓 妊娠结局 人体质量指数 高脂血症 随访研究 Eclampsia Pregnancy complications Age of onset Fetal growth retardation Pregnancy outcome Body mass index Hyperlipidemias Follow-up studies
  • 相关文献

参考文献15

  • 1谢幸,苟文丽.妇产科学[M].8版.北京:人民卫生出版社,2013:118-119.
  • 2WONG T Y, GROEN H, FAAS M M, et al. Clinical risk factors for gestational hypertensive disorders in pregnant women at high risk for developing preeclampsia[J]. Pregnancy Hypertens, 2013,3(4):248-253.
  • 3BARTON J R,SIBAI B M.Prediction and prevention of recurrent preeclampsia[J]. Obstet Gynecol, 2008,112(21):359-372.
  • 4American College of Obstetricians and Gynecologists; Task Force on Hypertension in Pregnancy, Hypertension in Pregnancy. Report of the American College of Obstetricians and Gynecollgists's Task Force on Hypertension in Pregnancy[J]. Obstet Gynecol,2013,122(5):1122-1131.
  • 5SURAPANENI T, BADA V P, NIRMALAN C P. Risk for recurrence of pre-eclampsia in the subsequent pregnancy[J]. J Clin Diagn Res,2013,7 (12):2889-2891.
  • 6HERNANDEZ-DIAZ S,TOH S,CNATTINGIUS S. Risk of pre-eclampsia in first and subsequent pregnancies: prospective cohortstudy[J]. BMJ,2009,338: b2255.
  • 7李维,杨孜,王海玲,韩怡炜.子痫前期复发影响因素临床研究[J].中国实用妇科与产科杂志,2014,30(10):780-785. 被引量:11
  • 8MOSTELLO D, KALLOGJERI D,TUNGSIRIPAT R, et al. Recurrence of preeclampsia: effects of gestational age at delivery of the first pregnancy, body mass index, paternity, and interval between births[J]. Am J Obstet Gynecol,2008,199(1):55.e1-7.
  • 9BOGHOSSIAN N S, YEUNG E, MENDOLA P, et al. Risk factors differ between recurrent and incident preeclampsia: a hospital-based cohort study[J]. Ann Epidemiol,2014,24(12):871-7e3.
  • 10MAGNUSSEN E B, VATTEN L J, SMITH G D,et al. Hypertensive disorders in pregnancy and subsequently measured cardiovascular risk factors[J]. Obstet Gynecol, 2009,114(5):961-970.

二级参考文献9

共引文献1262

同被引文献135

  • 1高旖鑫,刘慧姝.妊娠期凝血因子变化及临床意义[J].中国综合临床,2012,28(z1):126-127.
  • 2廖念权,江安,李小清,等.重度子痫前期孕妇204例母婴结局分析[J].医学临床研究,2015(5):1021-1023.
  • 3Omur D, Hacivelioglu SO, Oguzalp H, et al. The effect of anaesthesia technique on maternal and cord blood ischae- mia-modified albumin levels during caesarean section: a randomized controlled study[J]. J Int Med Res, 2013,41 (4) : 1111-1119.
  • 4Huang QT,Zhang M,Zhong M,et al. Advanced glycation end products as an upstream molecule triggers ROS-in- duced sFlt-1 production in extravillous trophoblasts..a no- vel bridge between oxidative stress and preeclampsia[J]. Placenta,2013,34(12) :1177-1182.
  • 5Guedes-Martins L, Matos L,Soares A,et al. AGEs, con- tributors to placental bed vascular changes leading to pre- eclampsia[J]. Free Radic Res,2013,47(Suppll) :S70-80.
  • 6Heimrath J, Paprocka M,Czekanski A, et al. Pregnancy- induced hypertension is accompanied by decreased num- ber of circulating endothelial cells and circulating endo- thelial progenitor ceils [J]. Arch Immunol Ther Exp (Warsz) ,2014,62(4) :353-356.
  • 7Szpera Gozdziewicz A, Breborowicz GH. Endothelial dys- function in the pathogenesis of pre-eclampsia[J]. Front Biosci(Landmark Ed) ,2014,19(5) :734-746.
  • 8Petla LT,Chikkala R, Ratnakar KS, et al. Biomarkers for the management of pre-eclampsia in pregnant women[J]. Indian J Med Res,2013,138(1) :60-67.
  • 9Xiao J, Niu J, Ye X, et al. Combined biomarkers evalua- tion for diagnosing kidney injury in preeclampsia[J]. Hy- pertens Pregnancy, 2013,32 (4) : 439-449.
  • 10Scazzochio E, Munmany M, Garcia L, et al. Prognostic role of maternal neutrophil gelatinase-associated lipocalin in women with severe early-onset preeclampsia[J]. Fetal Diagn Ther, 2014,35(2) : 127-132.

引证文献18

二级引证文献91

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部